Association of LDL Cholesterol, Non–HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With StatinsS. Matthijs Boekholdt, John J.P. Kastelein, Benoît J. Arsenault et al.|JAMA|2012Cited by 800
Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI TrialValery T. Miller, Sally A. Shumaker, John C. LaRosa et al.|JAMA|1995Cited by 605
Distribution of Estimated 10-Year Risk of Recurrent Vascular Events and Residual Risk in a Secondary Prevention PopulationLotte Kaasenbrood, Frank L.J. Visseren, Pierre Amarenco et al.|Circulation|2016Cited by 275